Veradermics’ oral treatment for female pattern hair loss delivers positive study results
Pattern hair loss affects around 30 million women and 50 million men in the US
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Veradermics’ oral treatment for female pattern hair loss delivers positive study results
Pattern hair loss affects around 30 million women and 50 million men in the US
AstraZeneca agrees on $1.5bn deal with Dizal Pharmaceutical
The company will gain a novel oral treatment for lung cancer
Bristol Myers Squibb’s New Drug Application for mezigdomide accepted by FDA
Mezigdomide improves progression-free survival in patients with relapsed or refractory multiple myeloma
Alzheimer’s groups call for urgent global focus on women’s brain health
New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the Alzheimer’s Association
Communiqué Awards 2026: celebrating excellence in healthcare communications
This year’s Awards, held at the Grosvenor House Hotel in London on 2 July, included 32 categories
Latest content
POP Health appoints Stephanie O’Hagan as Senior Director
O’Hagan most recently spent a decade in senior leadership at Envision 90TEN
Read More
Cherry appoints Peter Henshaw as new Managing Director
Henshaw was most recently Managing Director at Mednet Health
Read More
Exonate appoints Olav Hellebø as CEO
Hellebø has previously held senior leadership roles at Schering-Plough, Novartis UK and UCB
Read More
The outcomes economy: where next for pharma?
‘In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’
Read More
Intelligence
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates
Read More
Launching into an AI-powered future: a prescription for success
Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies
Read More
ASCO 2026: the art of translation
Translating emerging science into care that works meaningfully in practice
Read More
Steering generative AI into the pharma fast lane
Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
Blogs
Latest
More Than Pink Walls: What Women-Centric Care Actually Requires
July 15, 2026 | Medscape Education|
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the …
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
July 14, 2026 | Real Chemistry|AI, Innovation, healthcarecommunications
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
July 2, 2026 | Medscape Education|#APEX2026
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
July 1, 2026 | Medscape Education|#HearFromHer #PretermBirth
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity …
Supporting our team with an award-winning mental health strategy
June 26, 2026 | Mednet|Making Health Whole, Mental Health Awareness, Mental Health Strategy
Mental health has been at the centre of our business since our inception. But that work doesn’t just extend to our client projects. Find out …
Infographic: Are data blind spots putting your launch at risk?
July 16, 2026 | Inizio|
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult …
Key takeaways from ASCO® 2026
July 16, 2026 | Inizio|
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed …
Why faster trials make participant understanding more important than ever
July 15, 2026 | Cuttsy + Cuttsy|Informed Consent, clinical trials, communication
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
July 8, 2026 | Cuttsy + Cuttsy|Digital, clinical trials, communication, design
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
July 2, 2026 | Cuttsy + Cuttsy|Patient-centricity, patient engagement
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.